Clinical Trial Update: Natural History of Patients With PH3 and a History of Stone Events

View source ↗

Summary

This completed clinical trial update describes the natural history of patients with Primary Hyperoxaluria Type 3 and a history of stone events.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria Type

Snippet

Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | Conditions: Primary Hyperoxaluria Type 3 | Status: COMPLETED